by Desiree Cobb-Olori | May 29, 2010
Menalled, L. B.; Patry, M.; Ragland, N.; Lowden, P. A.; Goodman, J.; Minnich, J.; Zahasky, B.; Park, L.; Leeds, J.; Howland, D.; Signer, E.; Tobin, A. J.; Brunner, D. PLoS One 2010, 5, e9793.
by Desiree Cobb-Olori | May 27, 2010
Baker, K.; Wray, S.; Ritter, R.; Mason, S.; Lanthorn, T.; Savelieva, K. 2010, 9, 562-574.
by Desiree Cobb-Olori | May 25, 2010
Marcellino, D.; Suárez-Boomgaard, D.; Sánchez-Reina, M.D.; Aguirre, J.A.; Yoshitake, T.; Yoshitake, S.; Hagman, B.; Kehr, J.; Agnati, L.F.; Fuxe, K.; Rivera, A. J Neural Transm 2010, 117, 681-687.
by Desiree Cobb-Olori | Mar 20, 2010
Galter, D.; Pernold, K.; Yoshitake, T.; Lindqvist, E.; Kehr, J.; Olson, L. 2010, 9, 173-181.
by Desiree Cobb-Olori | Oct 25, 2009
Foreman, M. M.; Hanania, T.; Eller, M.Eur J Pharmacol 2009, 602, 316-20.DOI: 10.1016/j.ejphar.2008.11.013 JZP-4 is a novel with anticonvulsant, antidepressant and antimania effects in preclinical models. It has some structural similarity to the sodium channel blocker,...
